Share
Share today's newsletter with a colleague
and get credit if they sign up for SmartBrief.
Referral Count:
3
Story being shared
Oxford wins FDA nod for patient-specific cranial system
The FDA has given Oxford Performance Materials 510(k) clearance to market its OsteoFab system. The implantable device, which is tailored to each patient, is designed to help replace skull voids caused by disease or trauma.
Or we can send an email on your behalf